GINO SANTINI
CIK 1276038 · Sr.VP, Corp. Strategy & BD · last filed 2026-06-10
GINO SANTINI is a Sr.VP, Corp. Strategy & BD who has filed 72 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing shows the insider exercised options covering $143.5K of COLL on Jun 10, 2026. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $122.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$122.83M
9
72
-$1.30M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COLL | Director | 112,483 | $34.64 | $3.90M | -$201.0K | 10 | 2026-06-10 |
| CMPS | Director | — | $12.08 | — | $0 | 3 | 2026-05-29 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Director | 0 | $116.30 | $0 | -$1.10M | 21 | 2023-10-06 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 31,756 | $19.00 | $603.4K | $0 | 9 | 2023-05-25 |
| Allena Pharmaceuticals, Inc. (ALNA) Delisted | Director | — | $0.07 | — | $0 | 4 | 2021-06-04 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Director | 0 | — | — | $0 | 10 | 2020-11-17 |
| ESPR | Director | 30,148 | $3.15 | $95.0K | $0 | 4 | 2019-04-29 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Director | — | — | — | $0 | 4 | 2016-10-25 |
| LLY | Sr.VP, Corp. Strategy & BD | 104,886 | $1133.00 | $118.84M | $0 | 6 | 2009-02-03 |
Recent Filings
72 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | COLL | Exer (M) | +8,700 | $143.5K | EDGAR |
| 2026-05-29 | CMPS | Grant (A) | — | $0 | EDGAR |
| 2026-05-18 | COLL | Grant (A) | +8,741 | $0 | EDGAR |
| 2025-08-19 | COLL | Mixed | +9,595 | $732 | EDGAR |
| 2025-06-13 | CMPS | Grant (A) | — | $0 | EDGAR |
| 2025-05-19 | COLL | Grant (A) | +9,791 | $0 | EDGAR |
| 2024-09-04 | CMPS | Grant (A) | — | $0 | EDGAR |
| 2024-05-16 | COLL | Grant (A) | +7,693 | $0 | EDGAR |
| 2023-11-13 | — | Mixed | −31,756 | -$603.4K | |
| 2023-10-06 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Disp (D) | −119,614 | -$13.94M | EDGAR |